Oncoinvent ASA: Second half 2025 results
OSLO, Norway, Feb. 26, 2026 /PRNewswire/ -- Oncoinvent (OSE: ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate...
Read moreDetailsOSLO, Norway, Feb. 26, 2026 /PRNewswire/ -- Oncoinvent (OSE: ONCIN), a biotech company developing a receptor-independent alpha radiopharmaceutical to eradicate...
Read moreDetails-Poster Presentation Selected as Late Breaking Abstract-SHANGHAI and BOSTON, Feb. 25, 2026 /PRNewswire/ -- Argo Biopharmaceutical Co., Ltd. (Argo Biopharma),...
Read moreDetailsShame, alcohol, and assumptions of "low risk" drive non-disclosureSEATTLE, Feb 25, 2026 /PRNewswire/ -- A new Testing.com survey of 7,895 U.S. adults...
Read moreDetailsDELMAR, Md., Feb. 25, 2026 /PRNewswire/ -- Rescuers are working to save over 100 cats from an alleged cruelty case in...
Read moreDetailsMEXICO CITY, Feb. 25, 2026 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma" or "the Company"),...
Read moreDetailsBALTIMORE, Feb. 25, 2026 /PRNewswire/ -- Mercy Medical Center, part of Mercy Health Services in Baltimore, Maryland, was recognized today...
Read moreDetailsStudy finds infants' immune systems respond very differently to the two viruses, with important treatment implications.MEMPHIS, Tenn. and FARMINGTON, Conn., Feb....
Read moreDetailsFormer Hologic executive brings nearly two decades of success in hospital sales and commercialization expertise to medical technology leader's boardCARLSBAD,...
Read moreDetailsHOUSTON, Feb. 25, 2026 /PRNewswire/ -- Specialty1 Partners (S1P), the leading doctor-founded and doctor-led dental specialty partnership organization in North...
Read moreDetailsThe tinnitus market is experiencing steady growth driven by rising global prevalence of hearing disorders and increased awareness of early...
Read moreDetails© 2025 World Lifestyler